Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 196

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 196
---
 amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted
cash flows expected to be generated by the assets. If such asset is considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the asset exceeds its fair value.

<div align='center'>F-11</div>

REVIUM RX.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Assets to
be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. During the years ended December 31,
2024 no impairment losses have been identified.

| i. | Research and development expenses: |

Research and
development expenses are charged to the statement of comprehensive loss as incurred.

In-Process
Research and Development assets, acquired in an asset acquisition (i.e., assets acquired outside a business combination transactions)
that are to be used in a research and development project which are determined not to have an alternative future use are charged to expense
at the acquisition date in accordance with ASC 730, “Research and Development”.

| j. | Severance pay: |

The subsidiary’s
liability for severance pay is subject to Section 14 of Israel’s the Severance Compensation Act, 1963 (“Section 14”),
pursuant to which all Subsidiary’s employees are included under Section 14, and are entitled only to monthly deposits, at a rate
of 8.33% of their monthly salary, made in the employee’s name with insurance companies. Under Israeli employment law, payments
in accordance with Section 14 release the subsidiary from any future severance payments in respect of those employees. The Company has
made all of the required payments as of December 31, 2024.

The fund is
made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination.

The severance
pay liabilities and deposits under Section 14 are not reflected in the consolidated balance sheets as the severance pay risks have been
irrevocably transferred to the severance funds.

Severance
expenses for the years ended December 31, 2024 amounted to $16.

| k. | Income taxes: |

The Company
accounts for income taxes in